Medicines and Related Substances Act, 1965
R 385
Banks Act, 1990 (Act No. 94 of 1990)RegulationsRegulations relating to BanksChapter III : Corporate Governance43. Public disclosureSubregulation (2)(e) Nature and extent of risk exposuresSubregulation (2)(g) |
| (g) | To the extent not already covered by the information required to be disclosed in terms of the provisions of paragraphs (a) to (f) above, an overview of the key aspects relating to— |
| (i) | the organisational structure relevant to risk management and control, including relevant risk-management strategies, policies and practices; |
| (ii) | the methods used to measure and manage risks; |
| (iii) | the principal accounting policies and procedures relevant to the interpretation of the bank's risk exposures; and |
| (iv) | basic business, management and corporate governance information; |
| (v) | the bank's compensation or remuneration policies, processes and procedures, including sufficiently detailed information related to— |
| (A) | the decision-making process used to determine the bank's compensation policy; |
| (B) | the most important design characteristics of the compensation system, including— |
| (i) | criteria used for performance measurement and risk adjustment; |
| (ii) | relevant matters related to the bank's deferral policy and vesting criteria; |
| (iii) | the parameters used for allocating cash versus other forms of compensation; |
| (vi) | the manner in which the bank treats insurance entities when the bank calculates its required capital and reserve funds. |
